Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sanofi Says China Sales Grew 47% to $370 Million in Q3

publication date: Nov 7, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sanofi reported its China revenues climbed 47% in Q3 to $370 million, a gain of $119 million. About one-third of that rise can be attributed to Sanofi’s acquisition of BMP Sunstone, whose sales were running about $40 million per quarter when the company was still an independent entity. The quarter puts Sanofi at an annual run rate of $1.5 billion for China revenues. More details....

Stock Symbol: (NYSE: SNY)

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...